Stonegate Capital Partners Updates Coverage on Seabridge Gold Inc. (NYSE: SA) 2Q26
Downlaod Report Here Seabridge’s 2Q26 results further strengthened the investment case around KSM, with the Company advancing an earn-in joint venture with its preferred partner while a new US$100M unsecured facility from a strategic investor provides funding flexibility to continue the feasibility-study and 2026 work program. The central investment question remains straightforward: KSM’s scale and […]
Stonegate Updates Coverage on NZX Limited (NZSE: NZX) 1H26
Download Report Here NZX’s 1H26 results modestly strengthen the forward setup, with Smart and Wealth Technologies providing increasingly visible growth while Capital Markets remains dependent on a normalization in issuance and trading activity. The 140 bps y/y margin decline to 35.6% appears largely tied to QuayStreet transition costs and investment rather than underlying deterioration, with […]
Stonegate Updates Coverage on Creative Media & Trust Corp. (NASDAQ: CMCT) 2Q26
Download Report Here CMCT’s 2Q26 results showed the first meaningful earnings benefit from its recapitalization, with Core FFO improving to $(3.4)M from $(5.9)M in 1Q26 as the March preferred redemption reduced the dividend burden. Underlying property performance was stronger than headline NOI suggests, with NOI excluding unconsolidated entity losses up 22.2% y/y to $12.5M, while […]
Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. (NASDAQ: ACOG) 2Q26
Download Report Here Alpha Cognition’s 2Q26 results showed continued expansion of the ZUNVEYL launch, with net product revenue increasing 71% q/q to $6.0M as bottles dispensed increased 37% to 8,294 and repeat prescribers increased 29% to 1,024. Commercial momentum occurred while downstream PBM implementation remained approximately 16%, with management indicating that demand growth continued into […]
Stonegate Capital Partners Updates Coverage on Pedevco Corp. (NYSE: PED) 2Q26
Download Report Here PEDEVCO’s 2Q26 sharpened the post-Juniper setup, with production down 16% q/q to 6,801 Boe/d as late-2025 D-J wells declined, but revenue rising 15% to $46.1M and Adjusted EBITDA improving to $18.7M as stronger crude pricing and stable absolute LOE offset lower volumes. Balance-sheet repair continues to progress, with leverage down to ~1x […]
Stonegate Capital Partners Updates Coverage on Aebi Schmidt Holding AG (NASDAQ: AEBI) 26Q2
Download Report Here AEBI’s 2Q26 results showed improving execution across the post-Shyft platform, with sales up 9% y/y and adjusted EBITDA up 22%, driving 90 bps of y/y margin expansion despite material inflation and before recent pricing fully works through backlog. Order intake increased 16% to $516M and backlog reached $1.28B, while the separate seven-year, […]
Stonegate Capital Partners Updates Coverage on Sky Harbour Group Corporation (NYSE: SKYH) 2Q26
Download Report Here Sky Harbour’s 2Q26 results showed improving operating leverage as revenue increased 50% y/y to $9.9M, adjusted EBITDA loss narrowed to $(0.9)M, and operating cash flow turned positive. Leasing momentum continues to build across the portfolio, with OPF occupancy reaching 80%, ADS Phase I at 98%, and management increasingly targeting meaningful pre-leasing ahead […]
Stonegate Updates Coverage on Burcon Nutrascience Corporation (TSX: BU) 1Q27
Download Report Here Burcon’s 1Q27 results show improving commercial traction, with revenue up 54% q/q and 273% y/y to $1.28M, active buying customers reaching 40, and repeat orders providing better visibility into recurring demand. The $1.76M inventory write-down obscured improving underlying plant economics, with the adjusted gross loss narrowing materially as Galesburg utilization scales. The […]
Stonegate Capital Partners Updates Coverage on NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI) 2Q26
Download Report Here NeOnc’s 2Q26 update meaningfully strengthens the clinical setup, with NEO100 meeting its Phase 2a primary endpoint and generating a notable overall survival signal of 26.09 months versus the 6–9 months management cites for current salvage therapy. The favorable safety profile, at-home administration, and lack of major toxicities support the potential for NEO100 […]
Stonegate Capital Partners Initiates Coverage on Abcourt Mines Inc. (TSXV: ABI)
Download Report Here Abcourt’s Q4 update improves the Sleeping Giant ramp-up setup despite lower gold production, as underground development, rehabilitation, drilling, and mill throughput all increased materially q/q. The production decline primarily reflected lower-grade development ore, while the expansion of working faces and transition toward long-hole stoping should provide greater feed flexibility and support […]